Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

Item
http://www.wikidata.org/entity/Q34042038
Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts.Therapeutic potential of ribozymes in haematological disorders.RNA-based gene therapy for HIV infection.Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNACleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effectsInhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vectorPhase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside.Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.Ribozymes: structure, function, and potential therapy for dominant genetic disorders.Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt.Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.Artificial capillary culture: expansion and retroviral transduction of CD4+ T-lymphocytes for clinical application.Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
P2860

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

Item
http://www.wikidata.org/entity/Q34042038
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Resistance to human immunodefi ...... n response element constructs.
@ast
Resistance to human immunodefi ...... n response element constructs.
@en
Resistance to human immunodefi ...... n response element constructs.
@nl
type
label
Resistance to human immunodefi ...... n response element constructs.
@ast
Resistance to human immunodefi ...... n response element constructs.
@en
Resistance to human immunodefi ...... n response element constructs.
@nl
prefLabel
Resistance to human immunodefi ...... n response element constructs.
@ast
Resistance to human immunodefi ...... n response element constructs.
@en
Resistance to human immunodefi ...... n response element constructs.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Resistance to human immunodefi ...... on response element constructs
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932